Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02763319

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • MorphoSys Research Site Anaheim, California, United States
  • MorphoSys Research Site Bakersfield, California, United States
  • Morphosys Research Site Burbank, California, United States
  • Morphosys Research Site Fresno, California, United States
View all 158 locations
View Trial Details
Completed

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

NCT04477486

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • NHO Nagoya Medical Center /ID# 221958 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 221565 Nagoya, Aichi-ken, Japan
  • Kyushu University Hospital /ID# 223299 Fukuoka, Japan
  • Hokkaido University Hospital /ID# 221662 Sapporo, Hokkaido, Japan
View Trial Details
Completed

New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

NCT02329080

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Facultni nemocnice Brno, Czechia
  • FNKV (Facultni Nemocnice Kralovske Vinohrady) Prague, Czechia
  • Vseobecna facultni nemocnice v Praze Prague, Czechia
  • Spedali Civili Brescia, Italy
View all 36 locations
View Trial Details
Completed

A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

NCT01776840

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tucson, Arizona, United States
  • Burbank, California, United States
  • La Jolla, California, United States
  • Stanford, California, United States
View all 201 locations
View Trial Details
Completed

AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)

NCT06511869

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Anhui Provincial Hospital (The First Affiliated Hospital of USTC) Hefei, Anhui, China
  • Peking university Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
View all 23 locations
View Trial Details

Related conditions